Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging

PURPOSE: Amplification of the HER2/neu gene and/or overexpression of the corresponding protein have been identified in approximately 20% of invasive breast carcinomas. Assessment of HER2 expression in vivo would advance development of new HER2-targeted therapeutic agents and, potentially, facilitate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielinski, Rafal, Hassan, Moinuddin, Lyakhov, Ilya, Needle, Danielle, Chernomordik, Victor, Garcia-Glaessner, Alejandra, Ardeshirpour, Yasaman, Capala, Jacek, Gandjbakhche, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401287/
https://www.ncbi.nlm.nih.gov/pubmed/22911732
http://dx.doi.org/10.1371/journal.pone.0041016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401287/
https://www.ncbi.nlm.nih.gov/pubmed/22911732
http://dx.doi.org/10.1371/journal.pone.0041016

Ejemplares similares